- Home
- RLAY vs FSBC Comparison
RLAY vs FSBC Comparison
Compare RLAY & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- FSBC
- Stock Information
- Founded
- RLAY 2015
- FSBC 2002
- Country
- RLAY United States
- FSBC United States
- Employees
- RLAY N/A
- FSBC N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- FSBC Banks
- Sector
- RLAY Health Care
- FSBC Finance
- Exchange
- RLAY Nasdaq
- FSBC Nasdaq
- Market Cap
- RLAY 620.4M
- FSBC 606.0M
- IPO Year
- RLAY 2020
- FSBC 2021
- Fundamental
- Price
- RLAY $2.62
- FSBC $27.74
- Analyst Decision
- RLAY Strong Buy
- FSBC Buy
- Analyst Count
- RLAY 10
- FSBC 4
- Target Price
- RLAY $19.33
- FSBC $36.13
- AVG Volume (30 Days)
- RLAY 2.5M
- FSBC 84.2K
- Earning Date
- RLAY 05-01-2025
- FSBC 04-28-2025
- Dividend Yield
- RLAY N/A
- FSBC 2.88%
- EPS Growth
- RLAY N/A
- FSBC N/A
- EPS
- RLAY N/A
- FSBC 2.26
- Revenue
- RLAY $10,007,000.00
- FSBC $119,214,000.00
- Revenue This Year
- RLAY N/A
- FSBC $24.83
- Revenue Next Year
- RLAY $544.28
- FSBC $13.57
- P/E Ratio
- RLAY N/A
- FSBC $12.31
- Revenue Growth
- RLAY N/A
- FSBC 4.22
- 52 Week Low
- RLAY $2.45
- FSBC $21.10
- 52 Week High
- RLAY $10.72
- FSBC $35.13
- Technical
- Relative Strength Index (RSI)
- RLAY 32.07
- FSBC 34.60
- Support Level
- RLAY $3.05
- FSBC $27.35
- Resistance Level
- RLAY $3.08
- FSBC $28.99
- Average True Range (ATR)
- RLAY 0.25
- FSBC 1.03
- MACD
- RLAY -0.04
- FSBC 0.02
- Stochastic Oscillator
- RLAY 11.64
- FSBC 18.04
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.